Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication
Open Access
- 1 September 2012
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (9), 4838-4844
- https://doi.org/10.1128/aac.00983-12
Abstract
No antiviral drugs currently exist for the treatment of enterovirus infections, which are often severe and potentially life threatening. Molecular screening of small molecule libraries identified fluoxetine, a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication. Fluoxetine did not interfere with either viral entry or translation of the viral genome. Instead, fluoxetine and its metabolite norfluoxetine markedly reduced the synthesis of viral RNA and protein. In view of its favorable pharmacokinetics and safety profile, fluoxetine warrants additional study as a potential antiviral agent for enterovirus infections.Keywords
This publication has 41 references indexed in Scilit:
- Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarctionCMAJ : Canadian Medical Association Journal, 2011
- Fluoxetine Disposition in Patients with Chronic Hepatitis C Treated with Interferon-αClinical Pharmacokinetics, 2010
- An Investigation of Epidemic Enterovirus 71 Infection in Taiwan, 2008The Pediatric Infectious Disease Journal, 2010
- Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy eraAIDS, 2010
- Outbreak of Life‐Threatening Coxsackievirus B1 Myocarditis in NeonatesClinical Infectious Diseases, 2009
- Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vectorVaccine, 2009
- Fatal Neonatal Myocarditis Caused by a Recombinant Human Enterovirus-B VariantThe Pediatric Infectious Disease Journal, 2008
- Evidence for Frequent Recombination within SpeciesHuman Enterovirus BBased on Complete Genomic Sequences of All Thirty-Seven SerotypesJournal of Virology, 2004
- Development and evaluation of a ‘real‐time’ RT‐PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samplesJournal of Medical Virology, 2002
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999